HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Irene Ghobrial, MD

Director, Michele & Steven Kirsch Laboratory, Senior Physician, Associate Professor of Medicine, Harvard Medical School, Active Medical Staff, Myeloma Program, Dana-Farber Cancer Institute

18 years treating Myeloma

Clinical Expertise

Dr. Ghobrial's research focuses on the study of multiple myeloma precursor conditions; monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma. She initiated the PCrowd Study at Dana Farber: an observational global trial to define who will and won't progress to active myeloma. Her goal is to cure myeloma by preventing disease progression from these early conditions. Dr. Ghobrial received her MD in 1995 from Cairo University School of Medicine, Egypt. She completed her Internal Medicine training at Wayne State University, Mich., and her Hematology/Oncology subspecialty training at Mayo Clinic College of Medicine, Minn. Dr. Ghobrial also conducts research in the area of homing and migration of B cells and novel therapeutic agents in Waldenstrom's macroglbulinemia and multiple myeloma.


Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube